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Abstract  
 
Management of pain plays an important role during prostate biopsy. Various types of management of pain 
plays an important role during prostate biopsy. Various types of anaesthetic methods have been used. The 
present study aimed to compare the efficacy and complication rate between periprostatic lidocaine 
infiltration and transrectal lidocaine gel in transrectal ultrasound guided prostate biopsy. All prostate biopsy 
patients were included except those with lidocaine, allergy, haemorrhagic diathesis, anticoagulation 
therapy, the inability to rate a visual analogue scale and inability to obtain consent. They were randomized  
into two groups. Group 1 received 20ml 2% transrectal lidocaine gel. Group 2 received 5ml 1% lidocaine 
infiltration for each periprostatic nerve block with 23-gauge spinal needle. After three minutes, prostate 
biopsy was performed with an 18 gauge 7-inch spring-loaded biopsy gun. Six biopsies were taken for each 
lobe. Pain during probe insertion, biopsy and immediately after the procedure was assessed using the 
Visual Analogue Scale. Any complication immediately after procedure, one day or after one week, was 
recorded. Mean pain score was lower after periprostatic lidocaine infiltration compared to transrectal 
lidocaine gel (3.1 + 1.9 versus 4.9 + 2.4, p = 0.027). There was no statistically significant difference in the  
complication rate. Transrectal ultrasound prostate biopsy using periprostatic lidocaine infiltration provides 
better anaesthesia as compared to the transrectal lidocaine gel application with no significant difference in 
complication. Thus, the use of periprostatic lidocaine infiltration in TRUS guided prostate biopsy is 
recommended. 
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Introduction 
Prostate cancer is the most frequently 
diagnosed cancer in males and the 
second leading cause of death. In 
Malaysia, the reported cases of prostate 
cancer in 2002 were 458 with 375 
mortalities. In 2003 itself, prostate 
cancer was the sixth most frequent 
cancer among the male population in 
Peninsular Malaysia. It accounts for 
6.4% of male cancers that year (1).
 
 
Transrectal ultrasound (TRUS) guided 
biopsy of the prostate is the standard 
investigation for detecting prostate 
cancer. The invention of ultrasound has 
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 led to the development of TRUS in 
which needle biopsy can be guided by 
ultrasound. It uses a special device 
(transducer) to produce images of the 
prostate. These real time images help to 
guide the biopsy needle to obtain 
prostate tissue samples (2). 
 
  
There are various ways in administering 
analgesia in TRUS biopsy such as oral 
tramadol, transrectal lidocaine gel, 
periprostatic lidocaine infiltration and 
intramuscular pethidine. Researchers 
have reported that transrectal lidocaine 
gel is a simple, safe and effective 
method of anaesthesia delivery before 
transrectal ultrasound guided prostate 
biopsy (3). Periprostatic lidocaine 
infiltration was first used for transrectal 
ultrasound-guided biopsy of the prostate 
by Nash et al. in 1996 (4). 
 
Therefore, this prospective, randomized-
controlled study was performed to 
compare the efficacy of transrectal 
lidocaine gel application with 
periprostatic lidocaine infiltration in 
reducing pain in TRUS – guided prostate 
biopsy besides assessing their 
complication rates. 
 
Materials and methods 
 
This was a randomized-controlled 
prospective study. Approval for this 
study was obtained from the Ethics 
Committee of the institution. All patients 
who underwent TRUS guided prostate 
biopsy were included in our study. 
Indications for biopsy included abnormal 
digital rectal examination and elevated 
prostate specific antigen (PSA) level The 
PSA cut-off value was 4 ng/ml. 
Exclusion criteria were lidocaine allergy, 
haemorrhagic diathesis, anticoagulation 
therapy, the inability to rate a visual 
analogue scale (VAS) and inability to 
obtain consent. 
 
The patients received ravin enema and 
500mg ciprofloxacin the morning prior 
to the procedure. After informed consent 
was obtained, patients were randomized 
via into two groups. Patients were placed 
in the left lateral position. Group 1 
patients received 20ml 2% transrectal 
lidocaine gel three minutes before 
biopsy. Group 2 patients received 5ml 
1% lidocaine periprostatic nerve block 
using 23-gauge spinal needle three 
minutes before biopsy. The biopsy was 
performed in an outpatient setting. The 
transrectal probe used was the standard 
7MHz endocavity biplanar probe. After 
three minutes, prostate biopsy was 
performed with an 18-gauge 7-inch 
spring-loaded biopsy gun. Six biopsies 
were taken for each lobe and giving a 
total of twelve core biopsies for each 
prostate. The length of each core was set 
at 15mm. The procedure was carried out 
by one designated urology consultant for 
this study. 
 
After completion of biopsy, patients 
were assessed for their pain score. The 
pain during probe insertion (VAS1), 
during biopsy (VAS2) and immediately 
after procedure was (VAS3) assessed 
using the Visual Analogue Scale (5). 
Among the three VAS of each patient, 
the highest pain score (VASmod) was 
used in calculating the mean. Any 
complication immediately after 
procedure, after one day or after one 
week, was also recorded. Assessment 
after the procedure was made via 
telephone. The complications assessed 
were haematuria, haematochezia, 
dysuria, fever, chills, rigor, urinary 
incontinence, urinary retention and 
haematospermia. 
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Table 1: Complication rates after TRUS biopsy 
 
Statistical analysis  
 
The differences in VAS pain scores 
between the two groups were analyzed 
by Mann-Whitney U test. Fisher test was 
used for comparing the complications 
between the two groups. 
 
Results 
 
A total of 29 male patients were enrolled 
for the study. Fourteen were randomised 
to transrectal lignocaine gel and the 
other fifteen to periprostatic lidocaine 
infiltration for anaesthesia. There was a 
significant difference in the mean pain 
score (VASmod) after transrectal 
lidocaine gel and periprostatic lidocaine 
infiltration (4.9 + 2.4 versus 3.1 + 1.9, p 
= 0.027) with patients receiving 
periprostatic lidocaine infiltration 
reporting significantly less pain. There 
was no statistically significant difference 
in the complication rate (Table.1). 
 
Discussion 
 
TRUS guided prostate biopsy has 
become an important diagnostic tool in 
the evaluation of patients suspected of 
having prostate cancer. Pain associated 
with prostate biopsy occurs 
predominantly when the needle 
penetrates the prostate capsule into the 
stroma. Maintenance and positioning of 
the ultrasound probe can also contribute 
to the discomfort (6). Thus prostate 
biopsy in the absence of anaesthesia is 
painful and therefore local anaesthesia 
should be offered to any male 
undergoing TRUS-guided prostate 
biopsy. 
 
The prostate gland receives both 
sympathetic and parasympathetic nerve 
supply to both stroma and glandular 
element. Nerve joins the neurovascular 
bundles, which pass along the 
posterolateral margins of the gland 
between the capsule and Denonvillier’s 
fascia. Introduction of lidocaine 
infiltration at these points will numb the 
entire gland since it dissects and spreads 
along the plane of Denonvillier’s fascia. 
Waiting for three minutes before 
performing the biopsy will enhance pain 
control (7).
 
 
 Transrectal 
lidocaine gel 
Periprostatic 
lidocaine infiltration 
p 
Haematuria 45.7% 35.7% 0.65 
Haematochezia 35.7% 26.7% 0.70 
Dysuria 21.4% 26.7% 1.00 
Fever 21.4% 6.7% 0.33 
Chills 14.3% 13.3% 1.00 
Rigor 7.1% 6.7% 1.00 
Urinary incontinence 14.3% 6.7% 0.60 
Urinary retention 21.4% 13.3% 0.65 
Haematospermia 7.1% 0.0% 0.48 
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 Lidocaine gel decreases pain and 
discomfort during probe insertion and 
rectal wall puncture by exerting local 
effect on the autonomic innervation of 
the rectal mucosa but has no influence 
on pain when the needle penetrates the 
prostate capsule. It is a simple, safe and 
effective method of anaesthesia (3).
 
 
There have been conflicting reports 
comparing these 2 methods for local 
anaesthesia during TRUS-guided 
prostate biopsy. Researchers have also 
found that periprostatic lidocaine 
infiltration was more effective than 
intrarectal lidocaine gel application (8). 
In contrast, other researchers concluded 
that there was no difference regarding 
pain between periprostatic lidocaine 
infiltration and transrectal lidocaine gel 
(9). In the same study, they waited for 
ten minutes after transrectal lidocaine 
gel application before performing the 
biopsy. This could be the reason for the 
different outcome as compared to our 
study.   
 
In terms of complications of TRUS 
biopsy, there was a higher rate of 
haematuria, haematochezia, fever, chills, 
urinary retention, urinary incontinence 
and haematospermia in the lidocaine gel 
group. However, these differences were 
not statistically significant. Our results 
were in agreement with earlier research 
reports (8,9). The higher rate of 
complications in the lidocaine gel group, 
though not significant, could be due to 
the difficulty in executing the biopsy in a 
patient who is uncooperative due to the 
pain. Interestingly, another group of 
researchers showed that transrectal 
ultrasound-guided prostatic biopsy 
performed without anaesthesia is a 
method well tolerated by most of his 
patients (10). In this study, only the first 
core location influenced pain and he 
recommended starting a biopsy at the 
base of the prostate. 
 
Conclusion 
In conclusion, this prospective 
randomized controlled study showed that 
transrectal ultrasound prostate biopsy 
using periprostatic lidocaine infiltration 
provides better anaesthesia as compared 
to the transrectal lidocaine gel 
application with no significant difference 
in complication. Thus, the use of 
periprostatic lidocaine infiltration in 
TRUS guided prostate biopsy is 
recommended for future clinical 
practice. 
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